SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 598 filers reported holding SEAGEN INC in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $375,824 | +2.1% | 1,772 | -7.4% | 0.04% | +7.3% |
| Q2 2023 | $368,273 | -34.3% | 1,914 | -30.9% | 0.04% | -38.8% |
| Q1 2023 | $560,336 | -76.6% | 2,768 | -85.2% | 0.07% | -77.7% |
| Q4 2022 | $2,399,410 | -24.0% | 18,671 | -19.1% | 0.30% | -28.2% |
| Q3 2022 | $3,158,000 | -23.0% | 23,081 | -0.4% | 0.42% | -19.4% |
| Q2 2022 | $4,100,000 | +25.4% | 23,173 | +2.1% | 0.52% | +37.6% |
| Q1 2022 | $3,270,000 | +62.2% | 22,703 | +74.1% | 0.38% | +60.2% |
| Q4 2021 | $2,016,000 | -13.8% | 13,038 | -5.4% | 0.24% | -19.5% |
| Q3 2021 | $2,340,000 | +46700.0% | 13,780 | +40429.4% | 0.29% | +29200.0% |
| Q2 2021 | $5,000 | – | 34 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |